Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Free Report) Director William W. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $14.06, for a total transaction of $35,150.00. Following the completion of the sale, the director now directly owns 25,273 shares in the company, valued at $355,338.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Tactile Systems Technology Stock Down 1.1 %
Shares of TCMD stock traded down $0.15 during trading hours on Friday, reaching $13.90. 197,746 shares of the stock were exchanged, compared to its average volume of 198,468. Tactile Systems Technology, Inc. has a 12-month low of $9.69 and a 12-month high of $26.11. The business’s fifty day moving average is $15.16 and its two-hundred day moving average is $14.21. The company has a debt-to-equity ratio of 0.13, a current ratio of 4.26 and a quick ratio of 2.99. The firm has a market capitalization of $330.26 million, a P/E ratio of 11.58 and a beta of 1.23.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last released its quarterly earnings data on Tuesday, February 20th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.25. Tactile Systems Technology had a net margin of 10.19% and a return on equity of 15.88%. The business had revenue of $77.65 million during the quarter, compared to analysts’ expectations of $78.85 million. During the same period in the previous year, the company earned $0.29 EPS. As a group, research analysts expect that Tactile Systems Technology, Inc. will post 0.58 EPS for the current fiscal year.
Hedge Funds Weigh In On Tactile Systems Technology
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised shares of Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a research report on Tuesday.
Read Our Latest Analysis on TCMD
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- What Do S&P 500 Stocks Tell Investors About the Market?
- MarketBeat Week in Review – 5/6 – 5/10
- What Investors Need to Know to Beat the Market
- Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
- Ride Out The Recession With These Dividend Kings
- Unity Software’s Mixed Q1, But Long-Term Outlook Remains Positive
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.